Nasopalpebral lipoma coloboma syndrome

Also Known As:

Nasopalpebral Lipoma-Coloboma Syndrome; Palpebral Coloboma-Lipoma Syndrome; Palpebral coloboma lipoma Syndrome

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Multiple Symmetrical Lipomatosis (Lipomatosis, Familial Benign Cervical)
2.	Lipomatosis
3.	Familial Multiple Lipomatosis

1.	Hwang, Lyahn K: 1 article (06/2015)
2.	Mlynek, Karolina S: 1 article (06/2015)
3.	Papay, Francis A: 1 article (06/2015)
4.	Riazi, Hooman: 1 article (06/2015)
5.	Tadisina, Kashyap Komarraju: 1 article (06/2015)
6.	Zins, James E: 1 article (06/2015)

Drugs and Important Biological Agents (IBA) related to Nasopalpebral lipoma coloboma syndrome:

1.	Fenofibrate (CiL)FDA LinkGeneric 06/01/2015 - "PubMed was searched for the following conditions: Familial multiple lipomatosis (FML), multiple symmetrical lipomatosis (MSL), congenital infiltrating lipomatosis of the face (CIL-F), and Nasopalpebral lipoma-coloboma syndrome (NLCS). "
2.	Fluorometholone (FML)FDA Link 06/01/2015 - "PubMed was searched for the following conditions: Familial multiple lipomatosis (FML), multiple symmetrical lipomatosis (MSL), congenital infiltrating lipomatosis of the face (CIL-F), and Nasopalpebral lipoma-coloboma syndrome (NLCS). "